Shenzhen Noposion Crop Science Past Earnings Performance
Past criteria checks 5/6
Shenzhen Noposion Crop Science has been growing earnings at an average annual rate of 7.5%, while the Chemicals industry saw earnings growing at 8.5% annually. Revenues have been growing at an average rate of 1.4% per year. Shenzhen Noposion Crop Science's return on equity is 9%, and it has net margins of 10.2%.
Key information
7.5%
Earnings growth rate
5.3%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 1.4% |
| Return on equity | 9.0% |
| Net Margin | 10.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Estimating The Intrinsic Value Of Shenzhen Noposion Crop Science Co., Ltd. (SZSE:002215)
Apr 02
Investors Still Aren't Entirely Convinced By Shenzhen Noposion Crop Science Co., Ltd.'s (SZSE:002215) Earnings Despite 26% Price Jump
Mar 04Shenzhen Noposion Crop Science (SZSE:002215) Might Be Having Difficulty Using Its Capital Effectively
Feb 27Revenue & Expenses BreakdownBeta
How Shenzhen Noposion Crop Science makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 4,601 | 472 | 786 | 128 |
| 31 Dec 23 | 4,120 | 236 | 685 | 119 |
| 30 Sep 23 | 4,119 | 307 | 732 | 131 |
| 30 Jun 23 | 4,187 | 345 | 708 | 128 |
| 31 Mar 23 | 4,337 | 381 | 714 | 125 |
| 31 Dec 22 | 4,265 | 328 | 694 | 126 |
| 30 Sep 22 | 4,404 | 276 | 726 | 113 |
| 30 Jun 22 | 4,522 | 323 | 727 | 110 |
| 31 Mar 22 | 4,556 | 323 | 732 | 110 |
| 01 Jan 22 | 4,501 | 305 | 742 | 107 |
| 30 Sep 21 | 4,112 | 212 | 717 | 99 |
| 30 Jun 21 | 4,203 | 197 | 731 | 102 |
| 31 Mar 21 | 4,167 | 184 | 725 | 101 |
| 31 Dec 20 | 4,131 | 167 | 715 | 99 |
| 30 Sep 20 | 4,164 | 259 | 699 | 86 |
| 30 Jun 20 | 4,138 | 240 | 710 | 91 |
| 31 Mar 20 | 4,141 | 229 | 742 | 87 |
| 31 Dec 19 | 4,058 | 236 | 744 | 93 |
| 30 Sep 19 | 4,098 | 296 | 734 | 97 |
| 30 Jun 19 | 4,108 | 313 | 729 | 99 |
| 31 Mar 19 | 4,070 | 306 | 737 | 95 |
| 31 Dec 18 | 4,005 | 329 | 742 | 99 |
| 30 Sep 18 | 3,758 | 354 | 718 | 99 |
| 30 Jun 18 | 3,511 | 359 | 641 | 143 |
| 31 Mar 18 | 2,997 | 355 | 619 | 121 |
| 31 Dec 17 | 2,822 | 309 | 654 | 90 |
| 30 Sep 17 | 2,497 | 214 | 635 | 72 |
| 30 Jun 17 | 2,214 | -28 | 869 | 0 |
| 31 Mar 17 | 2,166 | -239 | 1,108 | 0 |
| 31 Dec 16 | 1,963 | -276 | 1,109 | 0 |
| 30 Sep 16 | 2,125 | -206 | 1,180 | 0 |
| 30 Jun 16 | 2,171 | -8 | 1,050 | 0 |
| 31 Mar 16 | 2,166 | 225 | 785 | 0 |
| 31 Dec 15 | 2,210 | 231 | 753 | 0 |
| 30 Sep 15 | 2,028 | 213 | 634 | 0 |
| 30 Jun 15 | 2,123 | 215 | 588 | 0 |
| 31 Mar 15 | 2,258 | 210 | 606 | 0 |
| 31 Dec 14 | 2,203 | 194 | 590 | 0 |
| 30 Sep 14 | 2,124 | 188 | 561 | 0 |
| 30 Jun 14 | 2,045 | 240 | 543 | 0 |
| 31 Mar 14 | 1,876 | 200 | 560 | 0 |
| 31 Dec 13 | 1,736 | 180 | 539 | 0 |
| 30 Sep 13 | 1,702 | 164 | 546 | 0 |
| 30 Jun 13 | 1,700 | 157 | 547 | 0 |
Quality Earnings: 002215 has high quality earnings.
Growing Profit Margin: 002215's current net profit margins (10.2%) are higher than last year (8.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002215's earnings have grown by 7.5% per year over the past 5 years.
Accelerating Growth: 002215's earnings growth over the past year (23.7%) exceeds its 5-year average (7.5% per year).
Earnings vs Industry: 002215 earnings growth over the past year (23.7%) exceeded the Chemicals industry -20.1%.
Return on Equity
High ROE: 002215's Return on Equity (9%) is considered low.